IDEAYA Biosciences to Showcase Clinical Data, Growth Drivers at Investor Events

IDEAYA Biosciences will participate in the Cantor Global Healthcare Conference, its 10-Year Anniversary R&D Day, and the Morgan Stanley 23rd Annual Global Healthcare Conference. The company will share clinical data updates, outline growth drivers, and discuss its long-term portfolio strategy. This is a strategic move to bolster investor relations and potentially attract new investments, but investors should remain cautious due to forward-looking statements.

IDEAYA Biosciences (NASDAQ: IDYA), a precision medicine oncology company, has announced its participation in three major investor events in September 2025. The company aims to share updates on clinical data, outline growth drivers, and discuss its long-term portfolio strategy. These events are part of IDEAYA's strategic move to bolster investor relations and potentially attract new investments.

The first event, the Cantor Global Healthcare Conference, will take place on September 3rd. IDEAYA will participate in a fireside chat with Yujiro S. Hata, President and Chief Executive Officer, hosted by Li Watsek, Director, Biotechnology Analyst. This event will provide investors with an opportunity to gain insights into the company's current initiatives and future plans.

On September 8th, IDEAYA will host its 10-Year Anniversary R&D Day. The event will feature multiple clinical data updates across the pipeline, outline upcoming catalysts, and review the company's long-term portfolio strategy. Dr. Arun D. Singh, Director of the Department of Ophthalmic Oncology at the Cole Eye Institute, Cleveland Clinic, will join members of the company's leadership team to discuss the latest advancements in precision oncology. Live audio webcasts will be available on the company's investor relations website, with replays accessible for 30 days post-event.

The Morgan Stanley 23rd Annual Global Healthcare Conference, scheduled for September 9th, will see IDEAYA's management participate in one-on-one investor meetings. A live audio webcast of the conference events, as permitted by the conference host, will be available at the "Investors/Events" section of the IDEAYA website at https://ir.ideayabio.com/events and/or through the conference host. A replay of available webcasts will be accessible for 30 days following the live event.

While these events provide an opportunity for investors to gain valuable insights, it is essential to remain cautious. The company's press release includes forward-looking statements, which should be taken with a degree of skepticism. Investors should review IDEAYA's current and future filings with the U.S. Securities and Exchange Commission for a full understanding of the risks and uncertainties associated with these statements.

References:
[1] https://www.stocktitan.net/news/IDYA/ideaya-biosciences-to-participate-in-upcoming-september-2025-itiwkdlfvv3l.html
[2] https://finance.yahoo.com/news/ideaya-biosciences-participate-upcoming-september-100000910.html